Cisplatin versus non-cisplatin based first-line chemotherapy for advanced urothelial carcinoma previously treated with peri-operative cisplatin

INTRODUCTION: The optimal choice of first-line chemotherapy in urothelial carcinoma (UC) patients who relapse after receiving peri-operative cisplatin-based chemotherapy (PCBC) is unclear. We investigated outcomes with cisplatin re-challenge vs. a non-cisplatin regimen in patients with recurrent met...

詳細記述

保存先:
書誌詳細
出版年:Clin Genitourin Cancer
主要な著者: Locke, Jennifer A, Pond, Gregory Russell, Sonpavde, Guru, Necchi, Andrea, Giannatempo, Patrizia, Paluri, Ravi Kumar, Niegisch, Guenter, Albers, Peter, Buonerba, Carlo, di Lorenzo, Giuseppe, Vaishampayan, Ulka N., North, Scott A., Agarwal, Neeraj, Hussain, Syed A., Eigl, Bernhard J.
フォーマット: Artigo
言語:Inglês
出版事項: 2015
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913522/
https://ncbi.nlm.nih.gov/pubmed/26589729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2015.10.005
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料